Treatment for liver cancer: From sorafenib to natural products.

Man S, Luo C, Yan M, Zhao G, Ma L, Gao W

DOI: 10.1016/j.ejmech.2021.113690
Published: 2021 Nov 15
Container: European journal of medicinal chemistry
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2021.113690,
  title = {Treatment for liver cancer: From sorafenib to natural products.},
  author = {Man S and Luo C and Yan M and Zhao G and Ma L and Gao W},
  year = {2021},
  journal = {European journal of medicinal chemistry},
  doi = {10.1016/j.ejmech.2021.113690},
  url = {https://doi.org/10.1016/j.ejmech.2021.113690}
}

RIS

TY  - JOUR
TI  - Treatment for liver cancer: From sorafenib to natural products.
AU  - Man S
AU  - Luo C
AU  - Yan M
AU  - Zhao G
AU  - Ma L
AU  - Gao W
PY  - 2021
JO  - European journal of medicinal chemistry
DO  - 10.1016/j.ejmech.2021.113690
UR  - https://doi.org/10.1016/j.ejmech.2021.113690
ER  -

APA

S, M., C, L., M, Y., G, Z., L, M., & W, G. (2021). Treatment for liver cancer: From sorafenib to natural products.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2021.113690

Source records

pubmed · retrieved 2026-09-27T01:14:55.205Z